Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2017 (2017), Article ID 1587610, 13 pages
https://doi.org/10.1155/2017/1587610
Case Report

Costello Syndrome and Umbilical Ligament Rhabdomyosarcoma in Two Pediatric Patients: Case Reports and Review of the Literature

1Pediatric Surgical Oncology Section, Oncology Service, Department of Hematology-Oncology, Hospital Nacional de Niños “Dr. Carlos Sáenz Herrera”, Paseo Colón, 1654-1000 San José, Costa Rica
2Oncology Section, Department of Pediatric Surgery, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain
3Institute of Medical and Molecular Genetics (INGEMM), Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Paseo de la Castellana 261, 28046 Madrid, Spain
4Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Calle Sinesio Delgado 4, 28029 Madrid, Spain

Correspondence should be addressed to Carlos Sánchez-Montenegro; gro.dirdam.dulas@mzehcnasc

Received 5 October 2016; Revised 20 December 2016; Accepted 28 December 2016; Published 19 January 2017

Academic Editor: Philip D. Cotter

Copyright © 2017 Carlos Sánchez-Montenegro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Quezada and K. W. Gripp, “Costello syndrome and related disorders,” Current Opinion in Pediatrics, vol. 19, no. 6, pp. 636–644, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Costello, “A new syndrome,” New Zealand Medical Journal, vol. 74, article 397, 1971. View at Google Scholar
  3. J. M. Costello, “A new syndrome: mental subnormality and nasal papillomata,” Australian Paediatric Journal, vol. 13, no. 2, pp. 114–118, 1977. View at Google Scholar · View at Scopus
  4. K. W. Gripp and A. E. Lin, “Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations,” Genetics in Medicine, vol. 14, no. 3, pp. 285–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Kerr, M.-A. Delrue, S. Sigaudy et al., “Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases,” Journal of Medical Genetics, vol. 43, no. 5, pp. 401–405, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Ahmadi and E. Harley, “Costello syndrome and the importance of cancer screening,” Archives of Otolaryngology—Head and Neck Surgery, vol. 136, no. 10, pp. 1028–1029, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Kerr, O. B. Eden, R. Dandamudi et al., “Costello syndrome: two cases with embryonal rhabdomyosarcoma,” Journal of Medical Genetics, vol. 35, no. 12, pp. 1036–1039, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. K. W. Gripp, C. I. Scott Jr., L. Nicholson et al., “Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol,” American Journal of Medical Genetics, vol. 108, no. 1, pp. 80–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. K. W. Gripp, A. E. Lin, D. L. Stabley et al., “HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation,” American Journal of Medical Genetics Part A, vol. 140, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar
  10. M. Feingold, “Costello syndrome and rhabdomyosarcoma,” Journal of Medical Genetics, vol. 36, no. 7, pp. 582–583, 1999. View at Google Scholar · View at Scopus
  11. S. M. White, J. M. Graham Jr., B. Kerr et al., “The adult phenotype in Costello syndrome,” American Journal of Medical Genetics A, vol. 136, no. 2, pp. 128–135, 2005. View at Publisher · View at Google Scholar
  12. G. Bisogno, A. Murgia, I. Mammi, M. S. Strafella, and M. Carli, “Rhabdomyosarcoma in a patient with cardio-facio-cutaneous syndrome,” Journal of Pediatric Hematology/Oncology, vol. 21, no. 5, pp. 424–427, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Sigaudy, G. Vittu, A. David et al., “Costello syndrome: report of six patients including one with an embryonal rhabdomyosarcoma,” European Journal of Pediatrics, vol. 159, no. 3, pp. 139–142, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Hinek, M. A. Teitell, L. Schoyer et al., “Myocardial storage of chondroitin sulfate-containing moieties in Costello syndrome patients with severe hypertrophic cardiomyopathy,” American Journal of Medical Genetics, vol. 133, no. 1, pp. 1–12, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. E. Lin, P. D. Grossfeld, R. M. Hamilton et al., “Further delineation of cardiac abnormalities in Costello syndrome,” American Journal of Medical Genetics, vol. 111, no. 2, pp. 115–129, 2002. View at Publisher · View at Google Scholar
  16. A. L. Estep, W. E. Tidyman, M. A. Teitell, P. D. Cotter, and K. A. Rauen, “HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy,” American Journal of Medical Genetics, vol. 140, no. 1, pp. 8–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kawame, M. Matsui, K. Kurosawa et al., “Further delineation of the behavioral and neurologic features in Costello syndrome,” American Journal of Medical Genetics, vol. 118A, no. 1, pp. 8–14, 2003. View at Publisher · View at Google Scholar
  18. B. Kerr, M. A. Einaudi, P. Clayton et al., “Is growth hormone treatment beneficial or harmful in Costello syndrome?” Journal of medical genetics, vol. 40, no. 6, article e74, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. O'Neal, J. Ramdas, W. E. Wood, and P. K. Pellitteri, “Parameningeal rhabdomyosarcoma in a patient with Costello syndrome,” Journal of Pediatric Hematology/Oncology, vol. 26, no. 6, pp. 389–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. W. Gripp, “Tumor predisposition in Costello syndrome,” American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol. 137C, no. 1, pp. 72–77, 2005. View at Publisher · View at Google Scholar
  21. Y. Aoki, T. Niihori, H. Kawame et al., “Germline mutations in HRAS proto-oncogene cause Costello syndrome,” Nature Genetics, vol. 37, no. 10, pp. 1038–1040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Abe, Y. Aoki, S. Kuriyama et al., “Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan: findings from a nationwide epidemiological survey,” American Journal of Medical Genetics Part A, vol. 158, no. 5, pp. 1083–1094, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. I. F. M. Lo, C. Brewer, N. Shannon et al., “Severe neonatal manifestations of Costello syndrome,” Journal of Medical Genetics, vol. 45, no. 3, pp. 167–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Menke, S. Pauli, M. Sigler et al., “Uniparental trisomy of a mutated HRASproto-oncogene in embryonal rhabdomyosarcoma of a patient with costello syndrome,” Journal of Clinical Oncology, vol. 33, no. 13, pp. e62–e65, 2015. View at Publisher · View at Google Scholar
  25. C. P. Kratz, L. Franke, H. Peters et al., “Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes,” British Journal of Cancer, vol. 112, no. 8, pp. 1392–1397, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. H. K. Ransom, “Sarcoma of the urachus: review of the literature with report of an additional case,” The American Journal of Surgery, vol. 22, no. 2, pp. 187–191, 1933. View at Publisher · View at Google Scholar · View at Scopus
  27. E. M. L.-T. Fernández, N. H. Siverio, R. L. Almaraz, L. M. Viota, J. R. Luis, and L. D. Flores, “Radical surgery and IVA-chemotherapeutic regimen to treat embryonal rhabdomyosarcoma of the urachus: case report,” Pediatric Hematology and Oncology, vol. 24, no. 7, pp. 543–550, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Ishikawa, T. Nishi, R. Yamada et al., “A case of urachal sarcoma in childhood: case report and review of the world literature,” Journal of the Japanese Society of Pediatric Surgeons, vol. 21, pp. 128–135, 1985. View at Google Scholar
  29. S. Yokoyama, Y. Hayashida, J. Nagahama et al., “Rhabdomyosarcoma of the urachus: a case report,” Acta Cytologica, vol. 41, no. 4, pp. 1293–1298, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. U. Schulz and C. P. O'Leary, “Spinal AVM, epidermal nevus, and rhabdomyosarcoma: a rare neurocutaneous syndrome?” Neurology, vol. 56, no. 3, pp. 395–397, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Cheikhelard, S. Irtan, D. Orbach et al., “Urachal rhabdomyosarcoma in childhood: a rare entity with a poor outcome,” Journal of Pediatric Surgery, vol. 50, no. 8, pp. 1329–1333, 2015. View at Publisher · View at Google Scholar
  32. K. W. Gripp, E. Hopkins, K. Sol-Church et al., “Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C,” American Journal of Medical Genetics, Part A, vol. 155, no. 4, pp. 706–716, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Tarnowski, G. Schneider, G. Amann et al., “RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas,” International Journal of Oncology, vol. 41, no. 3, pp. 995–1004, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-S. Yu, K. W. Kim, H.-J. Lee, Y.-J. Lee, C.-S. Yoon, and M.-J. Kim, “Urachal remnant diseases: spectrum of CT and US findings,” Radiographics, vol. 21, no. 2, pp. 451–461, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. C. P. Kratz, S. Rapisuwon, H. Reed, H. Hasle, and P. S. Rosenberg, “Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes,” American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, vol. 157, no. 2, pp. 83–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Kerr, M. L. Mucchielli, S. Sigaudy et al., “Is the locus for Costello syndrome on 11p?” Journal of Medical Genetics, vol. 40, no. 6, pp. 469–471, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Niihori, Y. Aoki, N. Okamoto et al., “HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome,” Journal of Human Genetics, vol. 56, no. 10, pp. 707–715, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Rosenberger, S. Meien, and K. Kutsche, “Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with costello syndrome,” Human Mutation, vol. 30, no. 3, pp. 352–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. R. DeBaun, “Screening for cancer in children with Costello syndrome,” American Journal of Medical Genetics, vol. 108, no. 1, pp. 88–90, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. K. W. Gripp, H. Kawame, D. H. Viskochil, and L. Nicholson, “Elevated catecholamine metabolites in patients with Costello syndrome,” American Journal of Medical Genetics, vol. 128, no. 1, pp. 48–51, 2004. View at Google Scholar · View at Scopus
  41. M.-A. Delrue, B. Arveiler, and D. Lacombe, “Costello syndrome: clinical features and tumoral risk,” Archives de Pediatrie, vol. 9, no. 10, pp. 1059–1063, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Martínez-González and P. Lapunzina, Síndrome de Costello: Grupo de Trabajo sobre Cáncer en Síndrome Genéticos Polimarformativos (GT-CSGP), https://www.orpha.net/data/patho/Pro/es/CSGP-Costello-3.pdf.
  43. K. A. Rauen, A. Banerjee, W. R. Bishop et al., “Costello and cardio-facio-cutaneous syndromes: moving toward clinical trials in RASopathies,” American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol. 157, no. 2, pp. 136–146, 2011. View at Publisher · View at Google Scholar · View at Scopus